Biggest challenge during pandemic was negotiating politics: Pfizer

Protectionism as a result of fear meant the governments closed down borders, making it difficult to export vaccines, says Albert Bourla, Pfizer's chief executive officer

Pfizer CEO Albert Bourla
Agencies
1 min read Last Updated : Jan 20 2023 | 12:46 AM IST

Pfizer’s chief executive says the biggest challenge the company and other vaccine-makers faced during the pandemic was negotiating the politics.

Albert Bourla, who was speaking on Thursday on a panel on pandemic preparedness at the World Economic Forum gathering in Davos, Switzerland, said mask-wearing, vaccine efficacy or questions about delivering the vaccines were all politicised and were constant obstacles for vaccine-makers.

He says “the biggest challenge ... was the political challenge”. He added that protectionism as a result of fear meant the governments closed down borders, making it difficult to export vaccines or bring in raw materials needed to make them.

Meanwhile, 39 organisations from nine countries, including Salesforce, Pfizer and AstraZeneca, have pledged to close gaps on global health equity. Those having signed the Global Health Equity Network Zero Health Gaps Pledge at the WEF Annual Meeting 2023 also include Anglo American, Deloitte, Gavi, Medtronic, Philips, Sanofi and Takeda. The pledge includes 10 key commitments all signatories have made to embed health equity principles throughout their operations, workforce and guiding philosophies.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :PfizerDavosWorld Economic Forum

Next Story